Top Stories Boehringer Ingelheim Halts Development of Cystic Fibrosis Therapy Boehringer Ingelheim has officially ceased development of its inhaled gene therapy for cystic fibrosis, which was still in the early stages of clinical trials.... Editorial17 February, 2026